Physician profile
Christen J Coats
NPI 1568812345
$216,467.39
in general payments reported to CMS, 2019-2025
26 companies · $107K in 2025
The $107K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,092 · 2020: $3,618 · 2021: $3,177 · 2022: $19K · 2023: $17K · 2024: $61K · 2025: $107K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $85K · Consulting Fee: $53K · Travel and Lodging: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $9,702 · Honoraria: $350 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $84,600.00 |
| Consulting Fee | $53,400.00 |
| Travel and Lodging | $23,326.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,075.00 |
| Food and Beverage | $9,701.71 |
| Honoraria | $350.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $76,194.94 | 2022-2025 | Miebo, Xiidra, Blink Nutritears |
| Sun Pharmaceutical Industries INC. | $51,872.99 | 2020-2025 | Cequa |
| Alcon Vision LLC | $41,782.67 | 2019-2025 | Total30, Tryptyr, Dailies Total1 |
| Abbvie INC. | $8,140.96 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Harrow Eye, LLC | $5,385.54 | 2024-2025 | Vevye |
| Dompe US, INC. | $5,140.23 | 2022-2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $5,017.41 | 2019-2023 | |
| Oyster Point Pharma, INC. | $4,979.87 | 2022-2024 | Tyrvaya, Ryzumvi |
| Thea Pharma INC. | $4,947.52 | 2023-2024 | Iyuzeh |
| Allergan, INC. | $2,707.98 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $2,558.40 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $2,449.38 | 2020-2022 | |
| Carl Zeiss Meditec, INC. | $2,186.73 | 2020-2025 | Cirrus Hd-Oct, Cirrus 6000 With Angioplex, Quatera 700 |
| Tearlab Corp | $1,000.00 | 2024 | Scoutpro Osmolarity System |
| Shire North American Group INC | $816.21 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $490.97 | 2025 | Cirrus Hd-Oct |
| Glaukos Corporation | $306.84 | 2021-2024 | Ce-Marked Kxla System, Kxl1b-Ce-Marked Kxlsystem |
| Johnson & Johnson Vision Care, INC. | $158.43 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $95.00 | 2021 | |
| Biotissue Holdings INC. | $94.50 | 2025 | |
| Horizon Therapeutics Plc | $39.45 | 2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $32.61 | 2025 | Acthar |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Coopervision INC. | $17.78 | 2021 | |
| Aerie Pharmaceuticals, INC. | $17.47 | 2021 | |
| Sight Sciences, INC. | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christen Coats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.